(S (NP (DT An) (NN ability) (S (VP (TO to) (VP (VB map) (NP (NP (JJ seizure-generating) (NN brain) (NN tissue)) (, ,) (NN i.e.) (, ,) (NP (NP (DT the) (NN seizure) (VBN onset) (NN zone)) (PRN (-LRB- -LRB-) (NP (NNP SOZ)) (-RRB- -RRB-))) (, ,)) (PP (IN without) (S (VP (VBG recording) (NP (JJ actual) (NNS seizures))))))))) (VP (MD could) (VP (VB reduce) (NP (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (JJ invasive) (NNP EEG) (NN monitoring)))) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ drug-resistant) (NN epilepsy)))))))) (. .))
(S (NP (NP (DT A) (JJ widely-adopted) (NN practice)) (PP (IN in) (NP (DT the) (NN literature)))) (VP (VBZ is) (S (VP (TO to) (VP (VB compare) (NP (NP (NP (DT the) (NN incidence)) (PRN (-LRB- -LRB-) (NP (JJ events/time)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (JJ putative) (JJ pathological) (JJ electrophysiological) (NNS biomarkers)) (VP (VBN associated) (PP (IN with) (NP (JJ epileptic) (NN brain) (NN tissue))))))) (PP (IN with) (NP (NP (DT the) (NNP SOZ)) (VP (VBD determined) (PP (IN from) (NP (NP (JJ spontaneous) (NNS seizures)) (VP (VBN recorded) (PP (IN with) (NP (JJ intracranial) (NNP EEG))))))))) (, ,) (S (VP (ADVP (RB primarily)) (VBG using) (NP (DT a) (JJ single) (NN biomarker)))))))) (. .))
(S (NP (NP (JJ Clinical) (NN translation)) (PP (IN of) (NP (DT the) (JJ previous) (NNS efforts)))) (VP (NNS suffers) (PP (IN from) (NP (PRP$ their) (NN inability) (S (VP (TO to) (VP (VB generalize) (PP (IN across) (NP (JJ multiple) (NNS patients)))))))) (PP (IN because) (IN of) (NP (NP (PRN (-LRB- -LRB-) (DT a) (-RRB- -RRB-)) (NP (DT the) (JJ inter-patient) (NN variability))) (CC and) (NP (NP (PRN (-LRB- -LRB-) (NN b) (-RRB- -RRB-)) (NP (DT the) (JJ temporal) (NN variability))) (PP (IN in) (NP (DT the) (JJ epileptogenic) (NN activity))))))) (. .))
(S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBP report) (NP (NP (DT an) (ADJP (JJ artificial) (JJ intelligence-based)) (NN approach)) (PP (IN for) (S (VP (VBG combining) (NP (NP (JJ multiple) (JJ interictal) (JJ electrophysiological) (NNS biomarkers)) (CC and) (NP (PRP$ their) (JJ temporal) (NNS characteristics))) (PP (IN as) (NP (NP (DT a) (NN way)) (PP (IN of) (S (VP (NN accounting) (PP (IN for) (NP (DT the) (JJ above) (NNS barriers))))))))))))) (CC and) (VP (VBP show) (SBAR (IN that) (S (NP (PRP it)) (VP (MD can) (VP (ADVP (VB reliably)) (VB identify) (NP (NN seizure) (VBN onset) (NNS zones)) (PP (IN in) (NP (NP (DT a) (NN study) (NN cohort)) (PP (IN of) (NP (NP (CD 82) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (JJ underwent) (NP (NP (NN evaluation)) (PP (IN for) (NP (JJ drug-resistant) (NN epilepsy))))))))))))))))) (. .))
(S (NP (PRP$ Our) (NN investigation)) (VP (VBZ provides) (NP (NN evidence) (SBAR (IN that) (S (S (VP (VBG utilizing) (NP (NP (DT the) (JJ complementary) (NN information)) (VP (VBN provided) (PP (IN by) (NP (NP (JJ multiple) (JJ electrophysiological) (NNS biomarkers)) (CC and) (NP (PRP$ their) (JJ temporal) (NNS characteristics)))))))) (VP (MD can) (VP (ADVP (RB significantly)) (VB improve) (NP (DT the) (NN localization) (NN potential)) (PP (VBN compared) (PP (TO to) (NP (ADJP (RB previously) (VBN published)) (NN single-biomarker) (JJ incidence-based) (NNS approaches)))) (, ,) (S (VP (VBG resulting) (PP (PP (IN in) (NP (NP (DT an) (JJ average) (NN area) (PP (IN under) (NP (NNP ROC) (NN curve))) (PRN (-LRB- -LRB-) (NP (NNP AUC)) (-RRB- -RRB-)) (NN value)) (PP (IN of) (NP (CD 0.73))))) (PP (IN in) (NP (NP (DT a) (NN cohort)) (PP (IN of) (NP (CD 82) (NNS patients)))))))))))))) (. .))
(S (NP (PRP$ Our) (NNS results)) (ADVP (RB also)) (VP (VBP suggest) (SBAR (IN that) (S (S (VP (VBG recording) (NP (NNS durations) (PP (IN between) (NP (NP (NN ninety) (NNS minutes)) (CC and) (NP (CD two) (NNS hours))))))) (VP (VBP are) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB localize) (NP (NNP SOZs)) (PP (IN with) (NP (NP (NNS accuracies)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB prove) (ADJP (RB clinically) (JJ relevant)))))))))))))))) (. .))
(S (NP (NP (DT The) (JJ successful) (NN validation)) (PP (IN of) (NP (PRP$ our) (NN approach))) (PP (IN on) (NP (NP (DT a) (JJ large) (NN cohort)) (PP (IN of) (NP (CD 82) (NNS patients)))))) (VP (NNS warrants) (NP (NP (JJ future) (NN investigation)) (PP (IN on) (NP (NP (DT the) (NN feasibility)) (PP (IN of) (S (VP (VBG utilizing) (NP (NP (JJ intra-operative) (NNP EEG) (NN monitoring)) (CC and) (NP (JJ artificial) (NN intelligence))) (S (VP (TO to) (VP (VB localize) (NP (JJ epileptogenic) (NN brain) (NN tissue)))))))))))) (. .))
